Literature DB >> 5670883

Heparin in the treatment of venous thrombo-embolic disease: administration, control and results.

E F O'Sullivan, J Hirsh, R A McCarthy, G C de Gruchy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5670883     DOI: 10.5694/j.1326-5377.1968.tb29378.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  17 in total

Review 1.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Retroperitoneal haemorrhage and neuropathy complicating anticoagulant therapy.

Authors:  P V Curry; P A Bacon
Journal:  Postgrad Med J       Date:  1974-01       Impact factor: 2.401

3.  Heparin therapy: a simpler test of control.

Authors:  A J Handley
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

4.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

Review 5.  Intravenous heparin dosing: patterns and variations in internists' practices.

Authors:  B M Reilly; R Raschke; S Srinivas; T Nieman
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

6.  Intersubject variability in the anticoagulant response to heparin in vitro.

Authors:  T D Bjornsson; K M Wolfram
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17

Review 8.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

9.  Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems.

Authors:  J Hirsh; G S Hale; I G McDonald; R A McCarthy; A Pitt
Journal:  Br Med J       Date:  1968-12-21

Review 10.  Heparin therapy. Regimens and treatment considerations.

Authors:  T M Hyers
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.